Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroders Capital Global Innovation Trust Regulatory News (INOV)

Share Price Information for Schroders Capital Global Innovation Trust (INOV)

Share Price is delayed by 15 minutes
Get Live Data
16.60    0.10 (0.61%)
Bid:
16.60
Ask:
16.75
Spread: 0.15 (0.904%)
Market Cap: £105.47m
INOV Live PriceLast checked at - London Stock Exchange

Intraday Schroders Capital Global Innovation Trust Share Chart

Result of AGM

2 Jun 2026 16:12

RNS Number : 7138G
Schroders Capital Gbl Inn Tst PLC
02 June 2026
 

2 June 2026

Schroders Capital Global Innovation Trust plc

(the "Company")

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held earlier today, a poll was held on each of the resolutions proposed in the Notice of Annual General Meeting and each resolution was duly passed.

 

The full text of the resolutions is contained in the Notice of Annual General Meeting in the Company's Annual Report for the year ended 31 December 2025, available on the Company's web pages at www.schroders.com/inov

 

The results of the poll were as follows:

 

 

Resolution

Votes for (including discretionary)

%

Votes against

%

Votes total

% of ISC

Votes withheld

 

Ordinary business

1

To receive the Annual Report & Financial Statements

167,640,876

99.42

973,686

0.58

168,614,562

26.54%

743,109

2

To approve the Remuneration Report

159,771,455

94.88

8,629,754

5.12

168,401,209

26.50%

956,462

3

To re-elect Tim Edwards

158,257,009

93.89

10,303,092

6.11

168,560,101

26.53%

797,570

4

To re-elect Stephen Cohen

157,138,124

93.22

11,428,525

6.78

168,566,649

26.53%

791,022

5

To re-elect Jane Tufnell

157,120,862

93.19

11,475,046

6.81

168,595,908

26.54%

761,763

6

To re-appoint Ernst & Young LLP as Auditor

165,018,176

97.87

3,585,535

2.13

168,603,711

26.54%

753,960

7

To approve the Auditor's remuneration

165,079,709

97.95

3,454,809

2.05

168,534,518

26.53%

823,153

Special business

8

To renew the authority to allot shares

162,945,529

96.58

5,772,056

3.42

168,717,585

26.55%

640,086

9*

To approve the disapplication of pre-emption rights

160,082,966

94.91

8,580,123

5.09

168,663,089

26.55%

694,582

10*

To renew the authority to purchase own shares

167,862,890

99.46

908,963

0.54

168,771,853

26.56%

585,818

11*

To allow the Company to hold general meetings

on a minimum notice period of

14 clear days

163,727,567

97.04

4,988,504

2.96

168,716,071

26.55%

641,600

 

*Resolutions 9, 10, and 11 were passed as special resolutions.

 

A copy of the resolutions passed, other than resolutions concerning ordinary business, at today's AGM will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

Shareholders are entitled to one vote per share. Votes withheld are not a vote in law and are therefore not counted in the calculation of the percentages of the votes cast for and against a resolution. Where shareholders appointed the Chair as their proxy with discretion as to voting, their votes were cast in favour of the resolutions and their shares have been included in the "votes for" column.

 

The total number of ordinary shares of 1p each in issue and eligible to vote at the meeting was 635,361,925. The total number of voting rights is 635,361,925. The Company holds no shares in treasury.

 

Enquiries:

 

Francesca Davis

Schroder Investment Management Limited

020 7658 6000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUURVRNKUNRAR
Date   Source Headline
9th Jun 20265:11 pmRNSHolding(s) in Company
4th Jun 20267:00 amRNSUpdated Tender Timetable
2nd Jun 20264:13 pmRNSResult of General Meeting
2nd Jun 20264:12 pmRNSResult of AGM
7th May 20267:01 amRNSPublication of a Tender Offer Circular
7th May 20267:00 amRNSQuarterly NAV Announcement - 31 March 2026
15th Apr 20264:09 pmRNSDirector/PDMR Shareholding
9th Apr 20263:52 pmRNSDirector/PDMR Shareholding
1st Apr 20264:44 pmRNSAnnual Financial Report on NSM
31st Mar 20267:00 amRNSFinal Results
26th Feb 20262:56 pmRNSBlock listing Interim Review
11th Feb 20264:13 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSSale of Bluewater Bio Limited
28th Nov 20257:00 amRNSQuarterly NAV Announcement - 30 September 2025
27th Nov 20255:18 pmRNSHolding(s) in Company
27th Oct 20257:00 amRNSSale of Securiti AI
14th Oct 20255:12 pmRNSHolding(s) in Company
29th Sep 20255:08 pmRNSHolding(s) in Company
26th Sep 20254:04 pmRNSHolding(s) in Company
24th Sep 20254:48 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHalf-year Report
10th Sep 20255:09 pmRNSHolding(s) in Company
26th Aug 20254:57 pmRNSBlock listing Interim Review
22nd Aug 202511:42 amRNSDirector/PDMR Shareholding
22nd Aug 202511:40 amRNSDirector/PDMR Shareholding
22nd Aug 202511:38 amRNSDirector/PDMR Shareholding
13th Aug 20255:17 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNSResult of Tender Offer
16th Jul 20255:08 pmRNSHolding(s) in Company
11th Jul 20257:00 amRNSTender Offer Reminder
10th Jul 20254:23 pmRNSResult of General Meeting
4th Jul 20255:00 pmRNSHolding(s) in Company
20th Jun 20253:22 pmRNSHolding(s) in Company
19th Jun 20257:00 amRNSCirc re. Tender Offer
22nd May 20257:00 amRNSQuarterly NAV Announcement - 31 March 2025
21st May 20253:51 pmRNSResult of AGM
1st Apr 20254:12 pmRNSAnnual Financial Report on NSM
28th Mar 20257:00 amRNSFinal Results
25th Mar 20253:09 pmRNS-RVirtual Presentation
21st Mar 20254:12 pmRNSHolding(s) in Company
18th Mar 20254:45 pmRNSHolding(s) in Company
17th Mar 20259:40 amRNSSale of Araris Biotech
11th Mar 20254:38 pmRNSHolding(s) in Company
28th Feb 20255:10 pmRNSTotal Voting Rights
28th Feb 20253:53 pmRNSTransaction in Own Shares
27th Feb 20254:53 pmRNSResult of General Meeting
27th Feb 20253:40 pmRNSTransaction in Own Shares
26th Feb 20255:00 pmRNSTransaction in Own Shares
25th Feb 20254:53 pmRNSTransaction in Own Shares
24th Feb 20255:12 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.